Producers of Chinese herbal medicine, which has been widely used to treat COVID-19 patients and being distributed to Shanghai residents, are facing a heavy blow to its reputation after an influential health platform said on Sunday that the famous medicine cannot prevent people from infection with COVID-19.
BEIJING, April 18 Shares in one of China’s largest traditional medicine producers plunged today after reports questioned the efficacy of pills approved by the government as a coronavirus treatment. Shanghai authorities have joined their Hong Kong counterparts in handing out ‘Lianhua.
World News - SHANGHAI (AFP) Shares in one of China's largest traditional medicine producers plunged on Monday (April 18) after reports questioned the efficacy of pills approved by the government as a coronavirus treatment. Shanghai authorities have joined their Hong Kong. Read more at www.tnp.sg